companydata.dkcompanydata.dk
Back to company

Neo Biopharm ApS: Financial statements 2023

CVR: 42875708

Neo Biopharm ApS (CVR 42875708) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 528,359 and a net result of DKK 243,802. Equity amounted to DKK 2,108,709. The solvency ratio was 76.8%.

Gross Profit
528,359 kr.
Profit/Loss
243,802 kr.
Equity
2,108,709 kr.
Total Assets
2,745,273 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Neo Biopharm ApS publishes interim reportJan 20, 2023

Neo Biopharm ApS has published its interim report for the period November 23, 2021 – December 31, 2022.

About Neo Biopharm ApS

Neo Biopharm ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jakob Juul Rasmussen. The company is owned by Maryam Badri. In 2025, the company reported a gross profit of DKK -357,308 and a net result of DKK -271,403 compared with DKK 157,190 the year before. Equity amounted to DKK 1,994,496.

Other financial years

20252024